Advisor Group Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 250 shares of RVPH stock, worth $317. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 125
100.0%
Holding current value
$317
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RVPH
# of Institutions
40Shares Held
9.97MCall Options Held
133KPut Options Held
43.9K-
Armistice Capital, LLC New York, NY3.19MShares$4.05 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.83MShares$2.33 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.52MShares$1.93 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.3 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA685KShares$869,7020.01% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $26M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...